Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
5 papers
THCV is a cannabis compound that does not cause the “high” linked to THC. In animal studies it lowered appetite, increased feelings of fullness, and raised energy use, and some small studies in people with type 2 diabetes found lower fasting blood sugar versus placebo. Researchers say these findings make…
This paper is a systematic review of research on adults that looked at how eating disorders, body image, emotions, and self-esteem are linked. The authors searched three databases for papers from 2010–2024, screened 1,117 records, and included 6 studies, most of which had mostly female participants. The studies commonly found…
This article reviews evidence that tetrahydrocannabivarin (THCV), a non-psychoactive compound from Cannabis sativa, may help with obesity and type 2 diabetes. In lab and animal studies THCV reduced appetite, improved insulin sensitivity and glucose uptake, lowered fat buildup, and boosted energy function in fat and liver cells. Early human trials…
A placebo-controlled study of 44 adults (average age 51.8) tested daily mucoadhesive oral strips containing THCV and CBD for 90 days. Both the lower dose (8 mg THCV/10 mg CBD) and the higher dose (16 mg THCV/20 mg CBD) were associated with statistically significant weight loss versus placebo, and the…
This editorial reviews studies that look at how we measure diets to help manage weight and health. It says diet assessment must go beyond calories and include things like types of fats, gut effects, and emotional or mindful eating. The authors highlight specific study findings, limits of current tools, and…
